Previs, R. A., Armaiz-Pena, G. N., Lin, Y. G., Davis, A. N., Pradeep, S., Dalton, H. J., . . . Sood, A. K. (2015). Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian cancer. Mol Cancer Ther.
Citação norma ChicagoPrevis, Rebecca A., et al. "Dual Metronomic Chemotherapy With Nab-paclitaxel and Topotecan Has Potent Anti-angiogenic Activity in Ovarian Cancer." Mol Cancer Ther 2015.
Citação norma MLAPrevis, Rebecca A., et al. "Dual Metronomic Chemotherapy With Nab-paclitaxel and Topotecan Has Potent Anti-angiogenic Activity in Ovarian Cancer." Mol Cancer Ther 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.